Condition: Fibroadenoma · Breast Cancer Stage I · Sponsor: Columbia University
The objective of this study is to demonstrate the initial clinical feasibility of using Harmonic Motion Imaging (HMI) for Focused Ultrasound Surgery (FUS) guidance and monitoring in patients with benign and stage 1 non-metastatic breast cancers. The investigators hypothesize that changes in HMI parameters will inform progression of FUS ablation.
This description comes directly from the study's public registry record.
Elisa Konofagou, PhD · 212-342-0863 · ek2191@columbia.edu
Xiaoyue J Li, MSc · 435-757-9675 · xjl2102@columbia.edu
Always discuss trial participation with your own doctor first.
| Columbia University Irving Medical Center/NYP | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05219695